Wang L, Yue Z D, Zhao H W, Fan Z H, Wu Y F, Zhang Y, Qi R Z, Zhang K, Jiang L, Ding H G, Zhang Y N, Liu F Q
Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Department of Surgery, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100039, China.
Zhonghua Gan Zang Bing Za Zhi. 2022 Feb 20;30(2):220-223. doi: 10.3760/cma.j.cn501113-20201019-00561.
To investigate the practicability and safety of transjugular liver biopsy (TJLB). Data of 53 cases with transjugular liver biopsy from June 2015 to June 2020 were collected. LABS-100 was used in all patients who underwent transjugular liver biopsy. Among them, 45 cases and eight were biopsied via hepatic vein and intrahepatic segment of the inferior vena cava. The surgical indications, related complications, and postoperative pathological diagnosis were analyzed and summarized. TJLB was successful in all patients, with an average of 2.8 punctures per case. Satisfactory liver tissue and histopathological diagnosis was obtained in all patients. Two cases developed a cervical hematoma that was improved spontaneously, and one patient developed an intrahepatic hematoma that was improved after conservative treatment. TJLB is a practical and safe method for patients with contraindications to percutaneous liver biopsy.
